We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Probes Acquires Interfacial Dynamics

By HospiMedica staff writers
Posted on 30 Apr 2003
In a move to expand its bead-based assay systems, Molecular Probes, Inc. More...
(Eugene, OR, USA) has acquired Interfacial Dynamics Corp. (IDC, Portland, OR, USA). Financial terms were not disclosed.

IDC will become a wholly owned subsidiary of Molecular Probes. IDC was a pioneer in the production of surfactant-free, high-quality, reproducible latex microspheres. The acquisition gives Molecular Probes the ability to design and manufacture these latex microspheres for its own products and to offer a full line of microspheres to customers. Molecular Probes is a leading global provider of fluorescence-based detection assays.

"Adding IDC's outstanding capabilities in microsphere development and manufacturing to our expertise in fluorescence and conjugation, along with our relationships with major reagent, diagnostic, and instrument companies, gives us numerous opportunities to develop new bead-based assays and particle-based detection systems for a wide variety of uses,” said Anthony Martin, Ph.D., president and CEO of Molecular Probes.





Related Links:
Molecular Probes
Interfacial Dynamics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.